Covered recipient · General Payments record
JOSHUA P RAFF
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2023
$2,028.95
- Reported across 85 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $899.14 | 38 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $124.30 | 1 |
| PFIZER INC. | $62.59 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $61.96 | 3 |
| EMD Serono, Inc. | $61.50 | 2 |
| Incyte Corporation | $45.85 | 2 |
| Myriad Genetic Laboratories, Inc. | $43.14 | 2 |
| Daiichi Sankyo Inc. | $41.71 | 2 |
| SERVIER PHARMACEUTICALS LLC | $39.17 | 2 |
| Amgen Inc. | $34.77 | 2 |
| Celgene Corporation | $34.04 | 2 |
| Janssen Pharmaceuticals, Inc | $31.67 | 2 |
| Gilead Sciences, Inc. | $29.56 | 1 |
| Pharmacyclics LLC, An AbbVie Company | $28.79 | 1 |
| PROGENICS PHARMACEUTICALS, INC. | $28.73 | 1 |
| Janssen Biotech, Inc. | $27.41 | 1 |
| Novocure Inc. | $26.30 | 1 |
| JAZZ PHARMACEUTICALS INC. | $24.81 | 1 |
| Genentech USA, Inc. | $23.20 | 1 |
| Exelixis Inc. | $21.81 | 1 |
| Regeneron Healthcare Solutions, Inc. | $21.52 | 1 |
| Acerta Pharma LLC | $19.50 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.39 | 1 |
| GENZYME CORPORATION | $18.35 | 1 |
| Karyopharm Therapeutics Inc. | $14.60 | 1 |
| Coherus Biosciences Inc. | $14.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (38)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.